SAHZU Cardiac Rehabilitation Center is recognized as the "Certified Cardiac Rehabilitation Center" and the "National Demonstration of Cardiac Rehabilitation", becoming the fifth nationally accredited cardiovascular programs at SAHZU Heart Center, besides Heart Failure Center, Atrial Fibrillization Center, Hypertension Center and Chest Pain Center. The announcement was made at the Chinese Cardiovascular Health Conference on December 10, 2022.
The 2021 Chinese Hospital Ranking is released yesterday by Fudan Hospital Management Institution. According to the new ranking, SAHZU moves up five positions to the 11th with ten specialties listed top 10 in China.
See the world: Insights into Global Healthcare Service Innovation will take place from 2-5 PM on Nov. 12 (GMT+8) with online livestream and simultaneous interpretation in English and Chinese!
The SAHZU-Harvard International Medical Innovation Forum will be live-streamed on Nov. 10 and 11 with simultaneous interpretation in Chinese and English.
The closing ceremony of the International Wound Therapist Training Course is held last Wednesday on October 25, 2022.
Chair of SAHZU Nuclear Medicine/PET-CT Center Prof. ZHANG Hong is invited to deliver a plenary lecture titled PET Imaging in Pediatric Epilepsy: Current Status and Future Perspectives on the 13th Congress of the World Federation of Nuclear Medicine and Biology
FLAVOUR Study showed that in patients with intermediate stenosis, FFR guidance was noninferior to IVUS guidance in terms of the composite of death, myocardial infarction, or revascularization at 24 months.
In the board of officials meeting of Asia-Pacific Association of Cataract & Refractive Surgeons (APACRS) on August 27, Chair of SAHZU Eye Center Prof. YAO Ke officially takes over the presidency of APACRS in succession to Prof. Abhay Vasavada. This is the first time that a Chinese ophthalmologist chairing the Asia-Pacific Society in this field.
On July 27, SAHZU on behalf of its Eye Center, University Eye Clinic of the Ruprecht-Karls-University of Heidelberg, and EuroEyes sign on an agreement on a series of collaborative programs.
SAHZU is accredited as an A++ hospital again and sit in the 8th position out of 2508 Chinese public tertiary hospitals, ranking top 10 in China for three consecutive years.
A new study led by SAHZU researchers has identified ways by which some microbes might influence cancer immunotherapy, suggesting a potential microbial-based adjuvant approach to improve the responsiveness of immunotherapy. Their results were published in Cell1 in March 2024.
Italian surgeons Drs. Michele Cricrì and Federico Mongardini and Mexican surgeon Dr. Mitre Reyes have recently completed a three-month clinical training program at SAHZU Colorectal Surgery, as the second group of trainees of International Colorectal Surgery Training Academy of China (ICSTAC).
Dr. Lim Shin Hoei is an anesthesiologist from Penang, Malaysia. She was trained at SAHZU for trans-esophageal echocardiogram (TEE) and cardiothoracic anesthesia for six months. Congratulation to Dr. Lim!